SIRT1-mediated deacetylation of TRIM21 promotes IRF5 degradation and restrains type I interferon signatures in Sjögren’s disease
Translational Research · 2026-12 · 298 · 42-56
DOI: 10.1016/j.trsl.2026.09.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Research, 2026-12. Verfasst von Yuhao Xuan und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Science, Anhui Medical University, China; Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Inst…. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Natural Science Foundation of Anhui Province, National Natural Science Foundation of China, Anhui Medical University.
Abstract (Originalsprache)
INTRODUCTION: Persistently activated type I interferon (IFN) signaling is a key factor in glandular dysfunction of Sjögren's disease (SjD), with elevated "type I interferon signatures" observed in both peripheral blood and salivary gland tissues of affected patients. However, the intrinsic mechanisms suppressing this response remain incompletely understood. This study aims to investigate whether the NAD⁺-dependent deacetylase SIRT1 regulates the type I IFN signatures in salivary gland tissue by enhancing the ubiquitin-mediated degradation of IRF5 through modulation of TRIM21's E3 ubiquitin ligase activity. METHODS: Expression of SIRT1, TRIM21, IRF5, and interferon-stimulated genes (ISGs) was analyzed in labial gland tissues from SjD patients and validated in an antigen-induced SjD mouse model and human salivary gland epithelial cells (HSGECs). Protein-protein interactions and post-translational modifications were examined using co-immunoprecipitation, molecular docking, and site-directed mutagenesis approaches. RESULTS: In SjD patient tissues, mouse models, and IFN-α-stimulated HSGECs, SIRT1 expression was downregulated, whereas TRIM21, IRF5, and interferon-stimulated genes (ISG15, MX1, IFI44, and IFIT3) were significantly upregulated. Activation of SIRT1 attenuated type I IFN signatures by promoting TRIM21-mediated degradation of IRF5 and restoring secretory function in submandibular glands. Mechanistically, SIRT1 enhanced the E3 ubiquitin ligase activity of TRIM21 through site-specific deacetylation at lysine 374, thereby facilitating IRF5 ubiquitination and degradation. CONCLUSIONS: Our study reveals a novel SIRT1-TRIM21-IRF5 regulatory axis that modulates type I IFN responses in SjD, offering a potential therapeutic target for controlling immune-mediated inflammation in autoimmune diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy and Science, Anhui Medical University, China; Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Institute of Clinical Pharmacology, Anhui Medical University, China.
- The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
- School of Pharmacy and Science, Anhui Medical University, China; Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Institute of Clinical Pharmacology, Anhui Medical University, China. Elect…
Förderung
- Natural Science Foundation of Anhui Province
- National Natural Science Foundation of China
- Anhui Medical University
Zitieren
APA
Xuan, Y., Cheng, D., Xi, Q., Sun, L., Li, N., Lei, X., Yang, M., Liu, H., Li, L., Hu, W., & Wu, H. (2026). SIRT1-mediated deacetylation of TRIM21 promotes IRF5 degradation and restrains type I interferon signatures in Sjögren’s disease. Translational Research, 298, 42-56. https://doi.org/10.1016/j.trsl.2026.09.015
Vancouver
Xuan Y, Cheng D, Xi Q, Sun L, Li N, Lei X, et al. SIRT1-mediated deacetylation of TRIM21 promotes IRF5 degradation and restrains type I interferon signatures in Sjögren’s disease. Translational Research. 2026;298:42-56. doi:10.1016/j.trsl.2026.09.015
BibTeX
@article{Xuan2026,
author = {Xuan, Yuhao and Cheng, Danqian and Xi, Qi and Sun, Lejie and Li, Na and Lei, Xiaosheng and Yang, Meng and Liu, Hui and Li, Lijun and Hu, Wei and Wu, Huaxun},
title = {SIRT1-mediated deacetylation of TRIM21 promotes IRF5 degradation and restrains type I interferon signatures in Sjögren’s disease},
journal = {Translational Research},
year = {2026},
volume = {298},
pages = {42--56},
doi = {10.1016/j.trsl.2026.09.015}
}
EUVIMED